Diabetes drugs from Eli Lilly and Novo Nordisk, such as Mounjaro, Zepbound, Ozempic, and Wegovy, are expanding beyond ...

The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its ...

A little weight gain during the menopause is normal, but when it happens to a generation who came of age in the skinny-chic ...

Paul Curran, MPharm, a clinical pharmacist with Optimal You in the UK, says there is one nasty side effect, in particular, ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

Wegovy, which was approved in 2021 for obesity, contains the same key ingredient as Ozempic, called semaglutide, while Mounjaro uses a slightly different one, tirzepatide.

Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...

A new Mounjaro user has opened up on their experience taking the drug - including the one side effect they're struggling with ...